Morningstar
•
Nov 05, 2026
Becton, Dickinson and Company: Becton Dickinson Earnings: Results in Line, Guidance Too Cautious
Summary
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: Cardinal Health, Inc.
Nov 05, 2026
•
CAH
Analyst Report: Bio-Rad Laboratories, Inc.
Nov 05, 2026
•
BIO
Technical Assessment: Bullish in the Intermediate-Term
Nov 05, 2026
•
COR, CB
Analyst Report: Medtronic plc
Nov 05, 2026
•
MDT
Analyst Report: Boston Scientific Corporation
Nov 05, 2026
•
BSX
Analyst Profile
Alex Morozov
Regional Director
Alex Morozov, CFA, is director of European equity research for Morningstar Holland BV, a wholly owned subsidiary of Morningstar, Inc. He leads a team of equity analysts based in Europe who cover European and global companies across all major sectors of the economy.Before assuming his current role in 2014, Morozov was head of global healthcare equity research. Previously, he was a senior equity analyst, covering the medical instruments, life sciences, and diagnostics industries. Before joining Morningstar in 2006, Morozov worked in the insurance industry.Morozov holds a bachelor’s degree in finance, with a minor in mathematics, from the University of Missouri. He also holds the Chartered Financial Analyst® designation.
